Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF
2003
Multicenter Palmaz stent renal artery stenosis revascularization registry report: Four‐year follow‐up of 1,058 successful patients
2002
Acute kidney injury
2012 Standout
Comparison of Methods for Determining Renal Function Decline in Early Autosomal Dominant Polycystic Kidney Disease
2006
Inflammatory links between obesity and metabolic disease
2011 Standout
Small-Vessel Vasculitis
1997 Standout
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Predictive Performance of Renal Function Equations for Patients with Chronic Kidney Disease and Normal Serum Creatinine Levels
2002
Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial
2009
Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 Cases
2009
Identification of the Gene for Oral-Facial-Digital Type I Syndrome
2001
The role of Na+/H+ exchange in ischemia-reperfusion
1996
Renal-Artery Stenosis
2001 Standout
Cystatin C and Albuminuria as Risk Factors for Development of CKD Stage 3: The Multi-Ethnic Study of Atherosclerosis (MESA)
2011
The Biochemistry and Toxicity of Atractyloside: A Review
2000
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement
2004
Drug-Induced Hepatotoxicity
2003 Standout
Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy
1999
Systemic sclerosis
2017 Standout
Porphyrias
2010 Standout
Timing of New Black Box Warnings and Withdrawals for Prescription Medications
2002 Standout
Hepatotoxicity of herbal remedies.
1989
Volume Progression in Autosomal Dominant Polycystic Kidney Disease
2005
Type 2 diabetes as an inflammatory disease
2011 Standout
Chronic kidney disease
2011 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
Biologic markers for the early detection of acute kidney injury
2004
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
The versatility and universality of calcium signalling
2000 Standout
Sucralfate
1991
A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
1990 Standout
Dermatologic Conditions Seen in End‐Stage Renal Disease
2009
Acute kidney injury
2019 Standout
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
2004
Kidney-specific inactivation of Ofd1 leads to renal cystic disease associated with upregulation of the mTOR pathway
2010
Cardiorenal Syndrome
2008 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Rapidly Progressive Glomerulonephritis: Classification, Pathogenetic Mechanisms, and Therapy
1988
Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis
1995
Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
2002
Cytoplasmic Domain of the Ubiquitous Na+/H+ Exchanger NHE1 Can Confer Ca2+ Responsiveness to the Apical Isoform NHE3
1995
Sickle-cell disease
2010 Standout
Hepatorenal Disorders
2015
Chronic Kidney Disease and Functional Limitation in Older People: Health, Aging and Body Composition Study
2006
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
1993 Standout
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Determination of the production rate and non‐renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans
2005
Statins, inflammation and kidney disease
2011
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Adverse Drug Effects, Compliance, and Initial Doses of Antihypertensive Drugs Recommended by the Joint National Committee vs the Physicians' Desk Reference
2001
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Increment and impairment of adiponectin in renal failure
2009
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
2005 Standout
Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
2005
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Nephrogenic systemic fibrosis: A systemic fibrosing disease resulting from gadolinium exposure
2012
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Gait Speed and Survival in Older Adults
2011 Standout
Early detection of acute renal failure by serum cystatin C
2004
Mutational spectrum of the oral-facial-digital type I syndrome: a study on a large collection of patients
2008
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Imatinib mesylate blocks a non‐Smad TGF‐β pathway and reduces renal fibrogenesis in vivo
2005
Cystatin C: An Improved Estimator of Glomerular Filtration Rate?
2002
Sodium-Proton Exchange and Primary Hypertension
1995
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Antigen specificity in hydralazine associated ANCA positive systemic vasculitis
1995
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22
1987 Nature
The Tumor Lysis Syndrome
2011 Standout
Normal and abnormal aspects of proteinuria
1986
MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
2008
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
2006 Standout
Cetuximab-Related Tumor Lysis Syndrome in Metastatic Colon Carcinoma
2008
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Cby1 promotes Ahi1 recruitment to a ring-shaped domain at the centriole–cilium interface and facilitates proper cilium formation and function
2014 StandoutNobel
Inflammatory Mechanisms in Obesity
2011 Standout
Ischemic Cell Death in Brain Neurons
1999 Standout
Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
2005
Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition
1992
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.
1990 Standout
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
2004
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.
2010
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Four-Year Follow-up of Palmaz-Schatz Stent Revascularization as Treatment for Atherosclerotic Renal Artery Stenosis
1998
Works of A Botey being referenced
[Spleno-renal shunt using the retroperineal approach in the treatment of renovascular arterial hypertension].
1987
Intracellular calcium concentration and activation of the Na+/H+ exchanger in essential hypertension
1994
Interfamilial and Intrafamilial Variability of Clinical Expression in ADPKD1
2015
Acute Aluminum Encephalopathy in an Uremic Patient
1989
Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis
2002
Sporadic orofaciodigital syndrome type I presenting as end-stage renal disease
1997
Penicillamine-lnduced Rapidly Progressive Glomerulonephritis in a Patient with Rheumatoid Arthritis
1993
Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment
2000
Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor
2007
Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis
1998
[Acute kidney failure caused by Atractylis gummifera-L poisoning].
1992
[Prolonged hypotension after the first dose of atenolol (author's transl)].
1981
Acute Renal Failure Secondary to Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
2003
In Reply
2001
Intracellular calcium mobilization and activation of the Na+/H+ exchanger in platelets
1993
Improvement of renal function in azotaemic hypertensive patients after surgical revascularization
1988
Plasmapheresis treatment of idiopathic rapidly progressive glomerulonephritis.
1983
Parathyroid hormone and platelet cytosolic calcium concentration in essential hypertension
1995
Renin-induced massive proteinuria in man.
1979